Well Referenced

Tag: surgically menopausal women

Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial

This randomized, double-blind, placebo-controlled trial evaluated the efficacy of a 300 µg/day testosterone patch in surgically menopausal women with hypoactive sexual desire disorder (HSDD) on estrogen therapy. Over 24 weeks, the testosterone group experienced significant improvements in sexual desire (P < .001), satisfying sexual activity (mean increase of 1.56 episodes

Read More »
June 26, 2025 No Comments

Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder

This randomized, double-blind, placebo-controlled trial evaluated the effects of a 300 µg/day testosterone patch on hypoactive sexual desire disorder (HSDD) in surgically menopausal women receiving estrogen therapy. Over 24 weeks, the testosterone group experienced significant increases in satisfying sexual activity (mean increase of 1.56 episodes per 4 weeks vs. 0.73

Read More »
June 26, 2025 No Comments

Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial

This randomized, double-blind, placebo-controlled trial evaluated the safety and efficacy of a transdermal testosterone patch for treating hypoactive sexual desire disorder (HSDD) in surgically menopausal women. Participants receiving testosterone therapy experienced a 67% increase in satisfying sexual activity compared to a 48% increase in the placebo group (p

Read More »
June 26, 2025 No Comments

Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial

A randomized, placebo-controlled trial published in Menopause (2006) evaluated the efficacy and safety of a transdermal testosterone patch in surgically menopausal women with hypoactive sexual desire disorder (HSDD) undergoing concomitant estrogen therapy. The study found that testosterone therapy significantly improved sexual desire and other aspects of sexual function, including arousal,

Read More »
June 26, 2025 No Comments